RPT-UPDATE 2-U.S. FDA panel recommends approval of Novo Nordisk diabetes drug

May 24 (Reuters) - A U.S. advisory panel on Tuesday

recommended approval of a new diabetes drug made by Novo Nordisk

A/S that combines two of its existing treatments in a

fixed-dose combination...

Read more